Blood pressure treatment target in patients with diabetes mellitus—current evidence

References

• International Diabetes Federation (IDF). Diabetes atlas. 4th edition. Brussels: IDF; 2009.
   Google Scholar
• Finnish Diabetes Association. Program for the prevention of type 2 diabetes in Finland 2003–2010. Jyväskylä, Finland: Gummerus; 2003.
   Google Scholar
• Rosengren A, Wilhelmsen L. Diabetes and long-term risk of mortality from coronary and other causes in middle-aged Swedish men. A general population study. Diabetes Care. 1998;21:539–45.
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Rastenyte D, Qiao Q, Jakovljevic D. Epidemiology of macrovascular disease and hypertension in diabetes mellitus. In: De Fronso RA, Ferrannini E, Keen H, Zimmet P, editors. International textbook of diabetes mellitus. 3rd ed. Milan: John Wiley & Sons; 2004. p. 1345–70.
   Google Scholar
• Manuel D, Schultz S. Health-related quality of life and health-adjusted life expectancy of people with diabetes mellitus in Ontario, Canada, 1996–1997. Diabetes Care. 2004;27:407–14.
   PubMed Web of Science ®Google Scholar
• ; Emerging Risk Factors CollaborationSarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, . Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215–22. [Erratum, Lancet. 2010;376:958].
   PubMed Web of Science ®Google Scholar
• Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16:434–44.
   PubMed Web of Science ®Google Scholar
• Imperatore G, Cadwell BL, Geiss L, Saadinne JB, Williams DE, Ford ES, . Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971–2000. Am J Epidemiol. 2004;160:531–39.
   PubMed Web of Science ®Google Scholar
• Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335–42.
   PubMed Web of Science ®Google Scholar
• Cheung BMY, Ong KL, Cherny SS, Sham PC, Tso AWK, Lam KSL. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122:443–53.
   PubMed Web of Science ®Google Scholar
• Wang J, Geiss LS, Cheng YJ, Imeratore G, Saydash SH, James C, . Long-term and recent progress in blood pressure levels among U.S. adults with diagnosed diabetes, 1988–2008. Diabetes Care. 2011;34:1579–81.
   PubMed Web of Science ®Google Scholar
• Nilsson PM, Cederholm J, Zethelius B, Eliasson B, Eeg-Olofsson K, Gudbjörnsdottir S. Trends in blood pressure control in patients with type 2 diabetes—Data from the Swedish National Diabetes Register (NDR). Blood Press. 2011;20:348–54.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, . Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105–87.
   PubMed Web of Science ®Google Scholar
• Guidelines Sub-Committee. 1999 World Health Organization/International Society of Hypertension Guidelines for the management of hypertension. J Hypertens. 1999;17:151–83.
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, . Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206–52.
   PubMed Web of Science ®Google Scholar
• Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL Jr, . American Heart Association Council for High Blood Pressure Research; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Epidemiology and Prevention. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007;115:2761–88.
   PubMed Web of Science ®Google Scholar
• Sanchez RA, Ayala M, Baglivo H, Velazquez C, Burlando G, Kohlmann O, . Latin America Expert Group. Latin American Guidelines on Hypertension. J Hypertens. 2009;27: 905–22.
   PubMed Web of Science ®Google Scholar
• Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, Horiuchi M, . The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32:3–107.
   PubMed Web of Science ®Google Scholar
• Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, . European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14(Suppl 2):E1–40.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care. 2003;26(Suppl 1): S80–2.
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care. 2011;34(suppl 1):S11–61.
   Google Scholar
• Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, Caulfield MJ, . Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27:2121–58.
   PubMed Web of Science ®Google Scholar
• Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, . The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol. 2011;27:415–33.
   PubMed Web of Science ®Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S, . Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOTStudy Group. Lancet. 1998;351:1755–62.
   PubMed Web of Science ®Google Scholar
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703–13.
   Google Scholar
• Deedwania PC. Blood pressure control in diabetes mellitus: is lower always better, and how low should it go? Circulation. 2011;123:2776–8.
   PubMed Web of Science ®Google Scholar
• Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, . Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886–92. [Erratum, JAMA. 1997;277:1356.]
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Rastenyte D, Birkenhäger WH, Thijs L, Antikainen R, Bulpitt CJ, ., for the Systolic Hypertension in Europe Trial Investigators. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med. 1999;340:677–84.
   Google Scholar
• Fagard RH, Staessen JA, Thijs L, Gasowski J, Bulbitt CJ, Clement D, .; and syst-Eur Investigators. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Investigators. Circulation. 2000; 102:1139–44.
   PubMed Web of Science ®Google Scholar
• Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care. 2000;23(Suppl 2):B54–64.
   PubMed Web of Science ®Google Scholar
• Weber M, Bakris GL, Jamerson K, Weir M, Kjeldsen SE, Devereux RB, .; ACCOMPLISH Investigators. Cardiovascular events during differing hypertension therapies in patients with diabetes. J Am Coll Cardiol. 2010;56: 77–85.
   Google Scholar
• Patel A; , ADVANCE Collaborative GroupMacMahon S, Chalmers J, Neal B, Woodward M, Billot L, . Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829–40.
   PubMed Web of Science ®Google Scholar
• , ACCORD Study GroupCushman W, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, . Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362;1575–85.
   PubMed Web of Science ®Google Scholar
• McAlister FA, Zarnke KB, Campbell NRC, Feldman RD, Levine M, Mahon J, . The 2001 Canadian recommendations for the management of hypertension: part 2, therapy. Can J Cardiol. 2002;18:625–41.
   PubMed Web of Science ®Google Scholar
• Cooper-DeHoff RM, Gong Y, Handberg EM, Bavry AA, Denardo SJ, Bakris GL, . Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. JAMA. 2010; 304:61–8.
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Bahn GD, Moritz TE, Kaufman D, Abraira C, Duckworth W; VADT Study Group. Blood pressure and cardiovascular disease risk in the Veterans Affairs Diabetes Trial. Diabetes Care. 2011;34:34–8.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Gaxiola E, Messerli FH, Mancia G, Erdine S, Cooper-DeHoff R; INVEST Investigators. Clinical outcomes in the diabetes cohort of the International Verapamil SR-Trandolapril Study. Hypertension. 2004;44:637–42.
   PubMed Web of Science ®Google Scholar
• Bangalore S, Kumar S, Lobach I, Messerli FH. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analysis of randomized trials. Circulation. 2011;123:2799–10.
   PubMed Web of Science ®Google Scholar
• Reboldi G, Gentile G, Angeli F, Ambrosio G, Mancia G, Verdecchia P. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients. J Hypertens. 2011:29: 1253–69.
   PubMed Web of Science ®Google Scholar
• Zanchetti A. Blood pressure targets of antihypertensive treatment: up and down the J-shaped curve. Eur Heart J. 2010;23:2837–40.
   Google Scholar